Development of novel quality control material based on CRISPR/Cas9 editing and xenografts for MLH1 protein deficiency testing

BACKGROUND: Mismatch repair deficiency (dMMR) status induced by MLH1 protein deficiency plays a pivotal role in therapeutic decision‐making for cancer patients. Appropriate quality control (QC) materials are necessary for monitoring the accuracy of MLH1 protein deficiency assays used in clinical lab...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Zhang, Runling, Tan, Ping, Wang, Meng, Chen, Yuqing, Zhang, Jiawei, Han, Dongsheng, Han, Yanxi, Li, Jinming, Zhang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128289/
https://www.ncbi.nlm.nih.gov/pubmed/33826163
http://dx.doi.org/10.1002/jcla.23746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128289/
https://www.ncbi.nlm.nih.gov/pubmed/33826163
http://dx.doi.org/10.1002/jcla.23746

Ejemplares similares